Literature DB >> 29286485

Characterization of Tumor Cells Using a Medical Wire for Capturing Circulating Tumor Cells: A 3D Approach Based on Immunofluorescence and DNA FISH.

Giulia Gallerani1, Claudia Cocchi2, Martine Bocchini3, Filippo Piccinini4, Francesco Fabbri4.   

Abstract

Circulating tumor cells (CTCs) are associated with poor survival in metastatic cancer. Their identification, phenotyping, and genotyping could lead to a better understanding of tumor heterogeneity and thus facilitate the selection of patients for personalized treatment. However, this is hampered because of the rarity of CTCs. We present an innovative approach for sampling a high volume of the patient blood and obtaining information about presence, phenotype, and gene translocation of CTCs. The method combines immunofluorescence staining and DNA fluorescent-in-situ-hybridization (DNA FISH) and is based on a functionalized medical wire. This wire is an innovative device that permits the in vivo isolation of CTCs from a large volume of peripheral blood. The blood volume screened by a 30-min administration of the wire is approximately 1.5-3 L. To demonstrate the feasibility of this approach, epithelial cell adhesion molecule (EpCAM) expression and the chromosomal translocation of the ALK gene were determined in non-small-cell lung cancer (NSCLC) cell lines captured by the functionalized wire and stained with an immuno-DNA FISH approach. Our main challenge was to perform the assay on a 3D structure, the functionalized wire, and to determine immuno-phenotype and FISH signals on this support using a conventional fluorescence microscope. The results obtained indicate that catching CTCs and analyzing their phenotype and chromosomal rearrangement could potentially represent a new companion diagnostic approach and provide an innovative strategy for improving personalized cancer treatments.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29286485      PMCID: PMC5755680          DOI: 10.3791/56936

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

Review 1.  CTC enumeration and characterization: moving toward personalized medicine.

Authors:  Angela Toss; Zhaomei Mu; Sandra Fernandez; Massimo Cristofanilli
Journal:  Ann Transl Med       Date:  2014-11

2.  Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases.

Authors:  Daniel B Costa; Alice T Shaw; Sai-Hong I Ou; Benjamin J Solomon; Gregory J Riely; Myung-Ju Ahn; Caicun Zhou; S Martin Shreeve; Paulina Selaru; Anna Polli; Patrick Schnell; Keith D Wilner; Robin Wiltshire; D Ross Camidge; Lucio Crinò
Journal:  J Clin Oncol       Date:  2015-01-26       Impact factor: 44.544

3.  Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.

Authors:  Makoto Maemondo; Akira Inoue; Kunihiko Kobayashi; Shunichi Sugawara; Satoshi Oizumi; Hiroshi Isobe; Akihiko Gemma; Masao Harada; Hirohisa Yoshizawa; Ichiro Kinoshita; Yuka Fujita; Shoji Okinaga; Haruto Hirano; Kozo Yoshimori; Toshiyuki Harada; Takashi Ogura; Masahiro Ando; Hitoshi Miyazawa; Tomoaki Tanaka; Yasuo Saijo; Koichi Hagiwara; Satoshi Morita; Toshihiro Nukiwa
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

4.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Authors:  Hossein Borghaei; Luis Paz-Ares; Leora Horn; David R Spigel; Martin Steins; Neal E Ready; Laura Q Chow; Everett E Vokes; Enriqueta Felip; Esther Holgado; Fabrice Barlesi; Martin Kohlhäufl; Oscar Arrieta; Marco Angelo Burgio; Jérôme Fayette; Hervé Lena; Elena Poddubskaya; David E Gerber; Scott N Gettinger; Charles M Rudin; Naiyer Rizvi; Lucio Crinò; George R Blumenschein; Scott J Antonia; Cécile Dorange; Christopher T Harbison; Friedrich Graf Finckenstein; Julie R Brahmer
Journal:  N Engl J Med       Date:  2015-09-27       Impact factor: 91.245

5.  Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients.

Authors:  Johannes C Fischer; Dieter Niederacher; Stefan A Topp; Ellen Honisch; Sarah Schumacher; Norma Schmitz; Luisa Zacarias Föhrding; Christian Vay; Imke Hoffmann; Nikola S Kasprowicz; Philip G Hepp; Svjetlana Mohrmann; Ulrike Nitz; Antje Stresemann; Thomas Krahn; Tanja Henze; Evelyn Griebsch; Katharina Raba; Jutta M Rox; Folker Wenzel; Christoph Sproll; Wolfgang Janni; Tanja Fehm; Christoph A Klein; Wolfram Trudo Knoefel; Nikolas H Stoecklein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-24       Impact factor: 11.205

6.  Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

Authors:  Alice T Shaw; Dong-Wan Kim; Kazuhiko Nakagawa; Takashi Seto; Lucio Crinó; Myung-Ju Ahn; Tommaso De Pas; Benjamin Besse; Benjamin J Solomon; Fiona Blackhall; Yi-Long Wu; Michael Thomas; Kenneth J O'Byrne; Denis Moro-Sibilot; D Ross Camidge; Tony Mok; Vera Hirsh; Gregory J Riely; Shrividya Iyer; Vanessa Tassell; Anna Polli; Keith D Wilner; Pasi A Jänne
Journal:  N Engl J Med       Date:  2013-06-01       Impact factor: 91.245

7.  A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.

Authors:  Nadia Saucedo-Zeni; Steffi Mewes; Robert Niestroj; Lukasz Gasiorowski; David Murawa; Piotr Nowaczyk; Tatiana Tomasi; Ekkehard Weber; Grzegorz Dworacki; Nils G Morgenthaler; Heike Jansen; Corinna Propping; Karolina Sterzynska; Wojciech Dyszkiewicz; Maciej Zabel; Marion Kiechle; Ute Reuning; Manfred Schmitt; Klaus Lücke
Journal:  Int J Oncol       Date:  2012-07-16       Impact factor: 5.650

8.  The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study.

Authors:  Gerit Theil; Kersten Fischer; Ekkehard Weber; Rita Medek; Raschid Hoda; Klaus Lücke; Paolo Fornara
Journal:  PLoS One       Date:  2016-08-01       Impact factor: 3.240

9.  Catch and Release: rare cell analysis from a functionalised medical wire.

Authors:  Shukun Chen; Amin El-Heliebi; Gerlinde Tauber; Tanja Langsenlehner; Michaela Pötscher; Karl Kashofer; Zbigniew T Czyż; Bernhard Polzer; Sabine Riethdorf; Andra Kuske; Gerd Leitinger; Klaus Pantel; Thomas Kroneis; Peter Sedlmayr
Journal:  Sci Rep       Date:  2017-02-24       Impact factor: 4.379

10.  Prognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysis.

Authors:  Jianwei Wang; Jianwei Huang; Ke Wang; Jianjun Xu; Jian Huang; Tao Zhang
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

View more
  3 in total

Review 1.  Possible role of circulating tumor cells in early detection of lung cancer.

Authors:  Cristina Poggiana; Elisabetta Rossi; Rita Zamarchi
Journal:  J Thorac Dis       Date:  2020-07       Impact factor: 3.005

Review 2.  CTCs 2020: Great Expectations or Unreasonable Dreams.

Authors:  Elisabetta Rossi; Francesco Fabbri
Journal:  Cells       Date:  2019-08-27       Impact factor: 6.600

3.  Synergistic inhibition of csal1 and csal3 in granulosa cell proliferation and steroidogenesis of hen ovarian prehierarchical development†.

Authors:  Hongyan Zhu; Ning Qin; Xiaoxing Xu; Xue Sun; Xiaoxia Chen; Jinghua Zhao; Rifu Xu; Birendra Mishra
Journal:  Biol Reprod       Date:  2019-11-21       Impact factor: 4.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.